title: HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?
authors.affiliation: Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York.
authors.forename: Mathew S
authors.initials: MS
authors.lastname: Maurer
authors.affiliation: Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York. Electronic address: dmm31@columbia.edu.
authors.forename: Donna
authors.initials: D
authors.lastname: Mancini
mesh_terms: D003920:Diabetes Mellitus / Q000175:diagnosis*; D005260:Female; D006333:Heart Failure / Q000453:epidemiology*; D006801:Humans; D008297:Male; D010641:Phenotype; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D013318:Stroke Volume / Q000502:physiology*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors
keywords: diabetes; heart failure with preserved ejection fraction